Illumina (ILMN)

Add to Watchlists
Create an Alert
184.74 +3.24  +1.79% NASDAQ Apr 26, 16:59 Delayed 2m USD

Illumina Research and Development Expense (Quarterly):

145.00M for March 31, 2017
View 4,000+ financial data types
View Full Chart

Illumina Research and Development Expense (Quarterly) Chart

Export Data
Save Image
Print Image

Illumina Historical Research and Development Expense (Quarterly) Data

View and export this data going back to 2000. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
March 31, 2017 145.00M
Dec. 31, 2016 129.92M
Sept. 30, 2016 125.92M
June 30, 2016 124.59M
March 31, 2016 123.99M
Dec. 31, 2015 114.35M
Sept. 30, 2015 99.23M
June 30, 2015 96.18M
March 31, 2015 91.77M
Dec. 31, 2014 142.95M
Sept. 30, 2014 85.08M
June 30, 2014 82.98M
March 31, 2014 77.04M
Dec. 31, 2013 76.73M
Sept. 30, 2013 70.96M
June 30, 2013 67.61M
March 31, 2013 61.45M
Dec. 31, 2012 56.91M
Sept. 30, 2012 54.06M
June 30, 2012 71.22M
March 31, 2012 48.84M
Dec. 31, 2011 45.51M
Sept. 30, 2011 50.40M
June 30, 2011 50.80M
March 31, 2011 50.20M
Dec. 31, 2010 45.80M
Sept. 30, 2010 44.80M
June 30, 2010 43.67M
March 31, 2010 43.68M
Dec. 31, 2009 40.37M
Sept. 30, 2009 34.41M
June 30, 2009 33.12M
March 31, 2009 32.73M
Dec. 31, 2008 28.34M
Sept. 30, 2008 27.57M
June 30, 2008 23.49M
March 31, 2008 20.56M
Dec. 31, 2007 20.05M
Sept. 30, 2007 19.75M
June 30, 2007 18.18M
March 31, 2007 15.96M
Dec. 31, 2006 8.826M
Sept. 30, 2006 7.744M
June 30, 2006 8.587M
March 31, 2006 8.216M
Dec. 31, 2005 7.436M
Sept. 30, 2005 7.078M
June 30, 2005 7.318M
March 31, 2005 5.893M
Dec. 31, 2004 5.262M

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About R&D Expense

R&D expenses are a line item from many companies' income statements.

R&D expense (short for research and development expense) is essentially the amount of money that a company spends to develop new products and services each year. For example, if a pharmaceutical firm hires research scientists to develop new drugs, the salaries of these researchers will generally be expensed in the R&D expense category.

Like marketing expenses, but unlike capital expenditures, R&D expenses are subtracted from revenues every year directly. Therefore, accountants treat R&D spending as an expense rather than as an investment, though there is continuous debate over whether this is the correct classification.

An investor looking at companies with large R&D expenditures should think hard about whether a single company's R&D spending is an expense (like buying rubber to produce tires) or whether it is an investment (like buying machinery to produce tires more efficiently). Determining the answer to that question can have a large impact on how the company is valued.
Learn More


ILMN Research and Development Expense (Quarterly) Benchmarks

Agilent Technologies 79.00M
Pacific Biosciences 16.26M
Intuitive Surgical 73.50M

ILMN Research and Development Expense (Quarterly) Range, Past 5 Years

Minimum 54.06M Sep 2012
Maximum 145.00M Mar 2017
Average 94.90M

ILMN Research and Development Expense (Quarterly) Excel Add-In Codes

  • Metric Code: r_and_d_expense
  • Latest data point: =YCP("ILMN", "r_and_d_expense")
  • Last 5 data points: =YCS("ILMN", "r_and_d_expense", -4)

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.


You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 7-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.


Start your free 7-Day Trial.

{{}} No credit card required.

Already a subscriber? Sign in.